Vildagliptin-Omega-3 combination therapy mitigates the diabetic effects on rats sublingual salivary glands via anti-oxidative and anti-apoptotic mechanisms
Functional Foods in Health and Disease · 23.04.2026 · 16 (4) · 346-359
DOI: 10.31989/ffhd.v16i4.1937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional Foods in Health and Disease, online erschienen am 23.04.2026. Verfasst von Ahmed O. Galal und 17 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with diabetes mellitus (DM) frequently have xerostomia (dry mouth) and hyposalivation. Whether xerostomia and hyposalivation are more common in DM patients than non-DM individuals is unclear. Aim of the study: We aimed to detect the diabetic effects on the sublingual salivary gland and investigate the therapeutic potential of Vildagliptin (a dipeptidyl peptidase-4 (DPP-4) inhibitor) and omega-3 polyunsaturated fatty acids (PUFAs), alone and in combination, in protecting sublingual salivary glands in streptozotocin (STZ)-induced diabetic rats.
Methods
Forty male albino rats were randomly allocated into control, diabetic untreated, diabetic + Vildagliptin, diabetic + omega-3, and diabetic + combination groups. After 8 weeks, biochemical markers of oxidative stress including: Glutathione (GSH); Malondialdehyde (MDA); Nitric Oxide (NO); Superoxide Dismutase (SOD); Total Antioxidant Capacity (TAC), and inflammation markers as Interleukins ((IL-1β, IL-6) and Tumor Necrosis Factor (TNF) and histological outcomes (acinar integrity, mucin content, apoptosis) were analyzed.
Results
Induction of diabetes in rats caused structural changes in the sublingual gland associated with fibrotic, apoptotic and inflammatory changes, treatment of diabetes with vildagliptin enhanced the previous changes, butthe combination therapy (vildagliptin plus omega 3) significantly reduced oxidative stress, suppressed inflammation, and preserved gland structure compared to monotherapies.
Conclusion
The synergistic efficacy of Vildagliptin-omega-3 in mitigating diabetic salivary gland damage, proposing a novel therapeutic strategy. Novelty of the Study: Although Omega-3 and vildagliptin, a DPP-4 inhibitor, are both well-known for their metabolic and antioxidant advantages, this study is the first to show how they integrate to protect salivary gland architecture from diabetes-related damage via dual mechanisms (antioxidative and antiapoptotic). This provides a novel therapeutic approach for treating diabetic xerostomia (dry mouth) with glycemic control. Keywords: Diabetes mellitus; salivary glands; Vildagliptin; Omega-3; xerostomia
Zitieren
APA
Galal, A. O., Ali, L. S., Ramadan, O., Taha, R. S., Awad, M. M., Abdelhay, O. M., Alasmar, A., Darwish, A. A. D., Elgndy, A. I., Meghawry, A. M., Diab, M., Mohammed, N. A., Abd-Allah, F. M., Amr, I. M., Elmitwalli, M. E., Omar, N. A. A., Amer, A. E., & Abdel-Hady, A. A. (2026). Vildagliptin-Omega-3 combination therapy mitigates the diabetic effects on rats sublingual salivary glands via anti-oxidative and anti-apoptotic mechanisms. Functional Foods in Health and Disease, 16(4), 346-359. https://doi.org/10.31989/ffhd.v16i4.1937
Vancouver
Galal AO, Ali LS, Ramadan O, Taha RS, Awad MM, Abdelhay OM, et al. Vildagliptin-Omega-3 combination therapy mitigates the diabetic effects on rats sublingual salivary glands via anti-oxidative and anti-apoptotic mechanisms. Functional Foods in Health and Disease. 2026;16(4):346-359. doi:10.31989/ffhd.v16i4.1937
BibTeX
@article{Galal2026,
author = {Galal, Ahmed O. and Ali, Lashin S. and Ramadan, Osama and Taha, Reda S and Awad, Moaaz M. and Abdelhay, Osama M. and Alasmar, Ala’a and Darwish, Anas A. Darwish and Elgndy, Afnan I. and Meghawry, Asmaa M. and Diab, Mahmoud and Mohammed, Nourelhuda A. and Abd-Allah, Fatma M. and Amr, Ibrahim M. and Elmitwalli, Mohammed E. and Omar, Nassar A. A. and Amer, Ahmed E. and Abdel-Hady, Alsayed A.},
title = {Vildagliptin-Omega-3 combination therapy mitigates the diabetic effects on rats sublingual salivary glands via anti-oxidative and anti-apoptotic mechanisms},
journal = {Functional Foods in Health and Disease},
year = {2026},
volume = {16},
number = {4},
pages = {346--359},
doi = {10.31989/ffhd.v16i4.1937}
}
EUVIMED